Angiodroid is a medtech company offering an automatic injection system for carbon dioxide angiography.
Angiodroid has raised $7.4M in total funding. The most recent round was Series A. The last funding was announced in February 2023.
Angiodroid's investors include CDP Venture Capital, Innogest Capital, Italian Angels for Growth, 8a+ Investments SGR, Air Liquide ALIAD.
Angiodroid is headquartered in San Lazzaro, Italy.
Angiodroid is a medtech company offering an automatic injection system for carbon dioxide angiography.
Angiodroid is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Angiodroid — Funding & Investors." VCBacked, February 27, 2023, https://www.vcbacked.co/company/angiodroid. Accessed July 19, 2026.
VCBacked. (2023). Angiodroid — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/angiodroid
{{cite web |title=Angiodroid — Funding & Investors |url=https://www.vcbacked.co/company/angiodroid |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated